Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
the sector and the S&P 500 during the same time frame, as seen in the chart below. The stock is currently trading below both its 50 and 200-day moving averages. Image Source: Zacks Investment Research Novo Nordisk's stock price primarily dipped due to disappointing third-quarter results announced earlier this month. NVO missed estimates for both earnings and revenues. This was mainly because Diabetes and Obesity care sales failed to meet investor expectations. Subsequently, management lowered its expectations for both sales and operating profit growth. The company is struggling to meet the heavy demand for its semaglutide (GLP-1 agonist) drugs, particularly Ozempic (for type II diabetes or T2D) and Wegovy (for weight management), in the United States as well as international markets. Eli Lilly LLY, whose tirzepatide medicines, diabetes drug Mounjaro and weight loss medicine, Zepbound, are primary competitors to NVO's semaglutide drugs has been far more successful in increasing t
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk's Wegovy launches in China, offering obesity drug at a fraction of US prices [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop [Yahoo! Finance]Yahoo! Finance
- Useless Europe is sleepwalking into oblivion [Yahoo! Finance]Yahoo! Finance
- Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says [Yahoo! Finance]Yahoo! Finance
- Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says [Business Insider]Business Insider
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 11/19/24 - Form 6-K
- 11/18/24 - Form 6-K
- 11/14/24 - Form 6-K
- NVO's page on the SEC website